Fat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat

Obesity

Volumn 17, Issue 1, 2009, Pages 188-195

  Lim, Soo ^a   Son, Kyu R ^b   Song, In C ^b   Park, Ho S ^b   Jin, Cheng J ^a   Jang, Hak C ^a   Park, Kyong S ^b   Kim, Young Bum ^c   Lee, Hong K ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

ABDOMEN; ADIPOSE TISSUE; ANIMAL; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; FAT INTAKE; HISTOLOGY; INSULIN RESISTANCE; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; OXYGEN CONSUMPTION; RADIOGRAPHY; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ABDOMEN; ADIPOSE TISSUE; ANIMALS; AREA UNDER CURVE; BODY WEIGHT; DIETARY FATS; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; OBESITY; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 57949086076     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.486     Document Type: Article

References (46)

1. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7-18.
2. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789.
3. Chalkley SM, Hettiarachchi M, Chisholm DJ, Kraegen EW. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 1998;47:1121-1126.
4. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 1997;46:1768-1774.
5. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 1986;251:E576-E583.
6. Storlien LH, Jenkins AB, Chisholm DJ et al. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991;40:280-289.
7. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001;15:312-321.
8. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000;49:677-683.
9. Phillips DI, Caddy S, Ilic V et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996;45:947-950.
10. Forouhi NG, Jenkinson G, Thomas EL et al. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 1999;42:932-935.
11. Perseghin G, Scifo P, De CF et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-1606.
12. Banerji MA, Buckley MC, Chaiken RL et al. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995;19:846-850.
13. Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995;19:841-845.
14. Larson-Meyer DE, Heilbronn LK, Redman LM et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 2006;29:1337-1344.
15. Ryysy L, Hakkinen AM, Goto T et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000;49:749-758.
16. Pan DA, Lillioja S, Kriketos AD et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997;46:983-988.
17. Levin K, Daa SH, Alford FP, Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 2001;44:824-833.
18. He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001;50:817-823.
19. Boesch C, Slotboom J, Hoppeler H, Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MRspectroscopy. Magn Reson Med 1997;37:484-493.
20. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-671.
21. Szczepaniak LS, Babcock EE, Schick F et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999;276:E977-E989.
22. Krssak M, Falk PK, Dresner A et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-116.
23. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A et al. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 2001;50:2337-2343.
24. Jacob S, Machann J, Rett K et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999;48:1113-1119.
25. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001;50:1612-1617.
26. Bachmann OP, Dahl DB, Brechtel K et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001;50:2579-2584.
27. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006;119:S10-S16.
28. Fujimoto WY, Newell-Morris LL, Grote M, Bergstrom RW, Shuman WP. Visceral fat obesity and morbidity: NIDDM and atherogenic risk in Japanese American men and women. Int J Obes 1991;15(Suppl 2):41-44.
29. Yamashita S, Nakamura T, Shimomura I et al. Insulin resistance and body fat distribution. Diabetes Care 1996;19:287-291.
30. Yoshida S, Inadera H, Ishikawa Y et al. Endocrine disorders and body fat distribution. Int J Obes 1991;15(Suppl 2):37-40.
31. Ross R, Leger L, Guardo R, De GJ, Pike BG. Adipose tissue volume measured by magnetic resonance imaging and computerized tomography in rats. J Appl Physiol 1991;70:2164-2172.
32. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
33. Koenig W, Sund M, Frohlich M et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-242.
34. Weiss R, Dufour S, Groszmann A et al. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003;88:2014-2018.
35. Weiss R, Dufour S, Taksali SE et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362:951-957.
36. Perseghin G, Lattuada G, Danna M et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003;285:E1174-E1181.
37. Kautzky-Willer A, Krssak M, Winzer C et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 2003;52:244-251.
38. Greco AV, Mingrone G, Giancaterini A et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002;51: 144-151.
39. Bjorntorp P. Liver triglycerides and metabolism. Int J Obes Relat Metab Disord 1995;19:839-840.
40. Kuhlmann J, Neumann-Haefelin C, Belz U et al. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes 2003;52:138-144.
41. Yu JG, Javorschi S, Hevener AL et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002;51:2968-2974.
42. Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 2006;14(Suppl 1): 20S-24S.
43. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
44. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
45. Lim S, Jang HC, Lee HK et al. The relationship between body fat and C-reactive protein in middle-aged Korean population. Atherosclerosis 2006;184:171-177.
46. Sinha R, Dufour S, Petersen KF et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 2002;51:1022-1027.